Target intelligence / Profile preview

Leucine-rich repeat- and IQ domain-containing protein 1 (LRRIQ1)

Target
LRRIQ1
Molecular classification
Other (structural/nuclear-encoded mitochondrial protein), Protein with leucine-rich repeats (LRR) domain, Protein with calmodulin-binding IQ motif
01

Overview

Leucine-rich repeat- and IQ domain-containing protein 1 (LRRIQ1) is a conserved, nuclear-encoded mitochondrial protein primarily characterized by its structural domains: four leucine-rich repeats (LRRs), facilitating protein–protein interactions, and an IQ calmodulin-binding motif, which can bind calmodulin or similar proteins independently of calcium. LRRIQ1 is highly conserved across metazoans, with highest expression in the testis, specifically in germ cells and Leydig cells. In mice, knockout of Lrriq1 causes reduced sperm motility and fertility due to increased apoptosis in testicular germ cells, associated with decreased levels of inhibin B, a regulator of spermatogenesis. Human LRRIQ1 is genetically linked to certain hereditary conditions such as sclerosteosis 1 and autosomal recessive deafness, but there is no current evidence of its therapeutic targeting by drugs, nor is it established as a clinical biomarker or drug target.

Other names
LRRIQ1KIAA1801FLJ12303Leucine rich repeats and IQ motif containing 1Testicular tissue protein Li 111
02

Biological functions

Protein-protein interaction scaffold (due to LRR domains)Potential regulation of signal transductionRegulation of apoptosis in testicular germ cellsRegulation of fertility via effects on inhibin B expression and sperm motility
03

Disease associations

Male infertility (evidence in knockout mice)Deafness, autosomal recessive 84A (gene association, not a validated therapeutic target)Sclerosteosis 1 (gene association)
04

Safety considerations

No drugs target LRRIQ1; disruption/knockout causes infertility via apoptosis in germ cells in mice
05

Biomarkers

Inhibin B (as a functional readout in research models, not validated for patient selection)

Beyond the preview

Go deeper on Leucine-rich repeat- and IQ domain-containing protein 1 (LRRIQ1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Leucine-rich repeat- and IQ domain-containing protein 1 (LRRIQ1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call